期刊文献+

CITED1 63-84氨基酸片段是影响其细胞定位与成骨作用的关键区域 被引量:1

Serine residues at position 63-84 are important for CITED1 nuclear translocation and osteoblast differentiation
下载PDF
导出
摘要 目的生物信息学分析发现CITED1 63-84氨基酸片段为其重要的功能片段,进一步研究CITED1 63-84氨基酸片段突变(丝氨酸突变为丙氨酸)是否影响其进核及成骨分化,探讨其在成骨分化过程中的生物学调控功能。方法 CITED1 63-84突变质粒(9S>A),CITED1质粒及空白质粒分别转染MC3T3-E1细胞,培养2 d,用100 nmol/L PTH(1-34)刺激细胞,行细胞免疫荧光实验,共聚焦镜下观察细胞内CITED1位置变化。将CITED1 63-84突变质粒(9S>A),CITED1质粒及空白质粒按相应体系转染MC3T3-E1细胞,分为两组,一组成骨诱导4周,另一组成骨诱导基础上进行10 nmol/L PTH(1-34)间歇刺激(每48 h刺激4 h)4周,测ALP酶活性及Ca离子浓度并进行ALP及茜素红染色。行RT-PCR实验分析成骨相关基因ALP2,RUNX2,OC的表达量。结果 PTH(1-34)可促进CITED1进核,将CITED1氨基酸63-84片段突变后,可明显抑制该反应。4周成骨诱导后,CITED1过表达明显抑制成骨细胞分化,ALP及Ca离子浓度明显低于对照组,而CITED1突变质粒(9S>A)过表达ALP及Ca离子浓度明显高于CITED1组,与对照组基本相同。进一步研究表明,CITED1过表达抑制PTH(1-34)诱导的成骨细胞分化,而CITED1突变质粒(9S>A)可逆转该反应。ALP染色及茜素红染色也验证了以上结论。RT-PCR结果提示:CITED1突变质粒(9S>A)过表达成骨相关基因ALP2,RUNX2,OC明显高于CITED1质粒过表达。结论 CITED1 63-84片段丝氨酸为其重要的功能位点,可影响其细胞进核及成骨分化。 Objective To determine the role of serine residues at position 63-84 of CITED1 in the nuclear translocation of CITED1 and osteoblast differentiation. Methods We engineered all the 9 phosphorylated serine residues of CITED1 with a serine-to-alanine mutation at position 63-84. MC3T3E1 ceils transfected with pCDNA3-CFP-CITED1 63-84 (9S〉A), pCDNA3-CFP-CITED1, and vehicle plasmid were examined with confocal laser scanning microscopy before and after treatment with 100 nmolFL parathyroid hormone [PTH(1-34)] to observe the changes in the intraceUular localization of CITED1. The transfected cells were induced for osteoblastic differentiation with mineralized solution in the absence or presence of 10 nmol/L PTH(1-34), and the changes in ALP activity and Ca2+ concentration were measured; RT-PCR was used to detect the changes in ALP2, RUNX2, and OC gene expressions after the treatments. Results PTH(1-34) promoted the nuclear translocation of CITED1 in MC3T3-E1 cells. The (63-84) 9S〉A mutation of CITED1 obviously suppressed its translocation and increased ALP activity and Ca2+~ levels in the cells, which led to enhanced mineralization in the cells with also increased expressions of ALP2, RUNX2, and OC. Conclusion The serine residues at position 63-84 of CITED1 play a vital role in the nuclear translocation of CITED1 and osteoblast differentiation.
出处 《南方医科大学学报》 CAS CSCD 北大核心 2013年第3期326-331,共6页 Journal of Southern Medical University
基金 国家自然科学基金(30973061) 南方医院院长基金(2009A002)~~
关键词 PTH 成骨分化 基因突变 细胞核移位 CITED1 parathyroid hormone osteoblast differentiation mutation nuclear translocation CITED1
  • 相关文献

参考文献16

  • 1Shioda T, Fenner MH, Isselbacher KJ. msgl, a novel melanocyte- specific gene, encodes a nuclear protein and is associated with pigmentation [J]. Proc Natl Acad Sci USA, 1996, 93(22): 12298- 303.
  • 2Bhattacharya S, Michels CL, Leung MK, et al. Functional role of p35srj, a novel p300/CBP binding protein, during transaetivation by HIF-I[J]. Genes Dev, 1999, 13(1): 64-75.
  • 3Shioda T, Lechleider R J, Dunwoodie SL, et al. Transcriptional activating activity of Smad4: roles of SMAD hetero-oligom- erization and enhancement by an associating transactivator[J]. Proc Natl Acad Sci USA, 1998, 95(17): 9785-90.
  • 4Plisov S, Tsang M, Shi G, et al. Citedl is a bifunctional transcriptional cofactor that regulates early nephronic patterning[J]. J Am Soc Nephrol, 2005, 16(6): 1632-44.
  • 5Shi G, Boyle SC, Sparrow DB, et al. The transcriptional activity of CITED1 is regulated by phosphorylation in a cell cycle-dependent manner[J]. J Biol Chem, 2006, 281(37): 27426-35.
  • 6Yang D, Guo J, Divieti P, et al. CBP/p300-interacting proteinCITED1 modulates parathyroid hormone regulation of osteoblastic differentiation[J]. Endocrinology, 2008, 149(4): 1728-35.
  • 7Yahata T, de Caestecker MP, Lechleider R J, et al. The MSG1 non-DNA-binding transactivator binds to the p300/CBP coactivators, enhancing their functional Link to the Smad transcription factors[J]. J Biol Chem, 2000, 275(12): 8825-34.
  • 8Yahata T, Shao W, Endoh H, et al. Selective coactivation of estrogen-dependent transcription by CITED1 CBP/p300-binding protein[J]. Genes Dev, 2001, 15(19): 2598-612.
  • 9Boyle S, Shioda T, Perantoni AO, et al. Citedl and cited2 are differentially expressed in the developing kidney but are i not required for nephrogenesis[J]. Dev Dyn, 2007, 236(8): 2321-30.
  • 10Howlin J, Mcbryan J, Napoletano S, et al. CITED1 homozygous null mice display aberrant pubertal mammary ductal morphogenesis [J]. Oncogene, 2006, 25(10): 1532-42.

同被引文献26

  • 1Deal C. Potential new drug targets for osteoporosis[J]. Nat Clin Pract Rheumatol, 2009, 5(1): 20-7.
  • 2Pennisi A, Ling W, Li X, et al. Consequences of daily administered parathyroid hormone on myeloma growth, bone disease, and molecular profiling of whole myelomatous bone [J]. PLoS One, 2010, 5(12): e15233.
  • 3Kraenzlin ME, Meier C. Parathyroid hormone analogues in the treatment of osteoporosis[J]. Nat Rev Endocrinol, 2011, 7 (11): 647-56.
  • 4Tseng YY, Su CH, Lui TN, et al. Prospective comparison of the therapeutic effect of teriparatide with that of combined vertebroplasty with antiresorptive agents for the treatment of new-onset adjacent vertebral compression fracture aider percutaneous vertebroplasty [J]. Osteoporos Int, 2012, 23 (5): 1613-22.
  • 5Oteo-Alvaro A, Matas JA, Alonso-Farto JC. Teriparatide (rh {[} 1-34] PTH) improved osteointegration of a hemiarthroplasty with signs of aseptic loosening[J]. Orthopedics, 2011, 34(9): E574-7.
  • 6Zati A, Sarti D, Malaguti MC, et al. Teriparatide in the treatment of a loose hip prosthesis[J]. J Rheumatol, 2011, 38(4): 778-80.
  • 7Wang J, Gilchrist A, Stem PH. Antagonist minigenes identify genes regulated by parathyroid hormone through G protein-selective and G protein co-regulated mechanisms in osteoblastic cells [J]. Cell Signal, 2011, 23(2): 380-8.
  • 8Yang D, Guo J, Divieti P, et al. Parathyroid hormone activates PKC-delta and regulates osteoblastic differentiation via a PLC-independent pathway[J]. Bone, 2006, 38(4): 485-96.
  • 9Guo J, Liu M, Yang D, et al. Phospholipase C signaling via the parathyroid hormone (PTH)/PTH-related peptide receptor is essential for normal bone responses to PTH [J]. Endocrinology, 2010, 151(8): 3502-13.
  • 10Yang D, Singh R, Divieti P, et al. Contributions of parathyroid hormone (PTH)/PTH-related peptide receptor signaling pathways to the anabolie effect of PTH on bone [J]. Bone, 2007, 40 (6): 1453-61.

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部